Results 61 to 70 of about 251 (129)

The prevalence and unique clinical features of CPFE among patients with connective tissue disease–associated interstitial lung disease: a retrospective, real-world study

open access: yesTherapeutic Advances in Respiratory Disease
Background: Combined pulmonary fibrosis and emphysema (CPFE) is a distinct yet clinically underrecognised syndrome. Interstitial pneumonia is a common pulmonary manifestation of connective tissue diseases (CTDs), and some CTD-interstitial lung disease ...
Shuwan Huang   +10 more
doaj   +1 more source

Single-cell RNA sequencing elucidates potential mechanisms of endothelial cells in lung region-specific repair and remodeling in combined pulmonary fibrosis and emphysema

open access: yesRespiratory Research
Background Combined pulmonary fibrosis and emphysema (CPFE) is a severe and progressive lung disease with limited therapeutic options and poor prognosis. CPFE manifests as emphysema and fibrosis in different lung regions and is frequently associated with
Huiyuan Hu   +11 more
doaj   +1 more source

Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis

open access: yesRMD Open, 2019
Objectives This multicentre study aimed to investigate the overall mortality of combined pulmonary fibrosis and emphysema (CPFE) in systemic sclerosis (SSc) and to compare CPFE-SSc characteristics with those of other SSc subtypes (with interstitial lung ...
Carlo Alberto Scirè   +31 more
doaj   +1 more source

Prognosis of combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis alone

open access: yesTherapeutic Advances in Respiratory Disease, 2019
Background: Combined pulmonary fibrosis and emphysema (CPFE) is a syndrome characterized by the coexistence of upper lobe emphysema and lower lobe fibrosis.
Chun-guo Jiang   +2 more
doaj   +1 more source

Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study.

open access: yesPLoS ONE
ObjectiveCombined pulmonary fibrosis and emphysema (CPFE) is a syndrome characterized by the coexistence of emphysema and fibrotic interstitial lung disease (ILD).
Shunsuke Mori   +8 more
doaj   +1 more source

Diagnosis and treatment of Combined Pulmonary Fibrosis and Emphysema (CPFE)

open access: yesWorld Journal of Advanced Research and Reviews, 2023
Combined pulmonary fibrosis and emphysema (CPFE) is a syndrome of combination pulmonary fibrosis and emphysema which is now widely found. Clinical characteristics of the CPFE are current or former heavy smoker, predominantly male, and symptom of shortness of breath on exertion.
openaire   +2 more sources

Cationic Cyclopentadienyliron Complex as a Novel and Successful Nucleating Agent on the Crystallization Behavior of the Biodegradable PHB Polymer

open access: yesMolecules, 2018
Cationic cyclopentadienyliron (CpFe+) is one of the most fruitful organometallic moieties that has been utilized to mediate the facile synthesis of a massive number of macromolecules.
Safaa H. El-Taweel   +3 more
doaj   +1 more source

Combined pulmonary fibrosis and emphysema: a narrative review

open access: yesFrontiers in Medicine
Combined pulmonary fibrosis and emphysema (CPFE) is defined as a clinical-radiological-physiological syndrome characterized by upper-lobe emphysema and fibrosis predominantly in the lower lobes.
Wenjing Zeng, Binmiao Liang, Xuemei Ou
doaj   +1 more source

Cardiac papillary fibroelastoma of a bicuspid aortic valve in an adolescent: A case report

open access: yesClinics and Practice, 2019
Cardiac papillary fibroelastomas (CPFE) are exceptional primary benign cardiac tumours, affecting the heart valves. We report here the case of a 15-year-old boy in whom echocardiography performed for non-specific chest pain during follow-up for bicuspid ...
Sarah Dénes   +3 more
doaj   +1 more source

Deterioration of Respiratory Symptoms in Uncontrolled CPFE: A Case Report

open access: yesJurnal Respirasi
Introduction: Chronic obstructive pulmonary disease (COPD) has a global impact on health and increases healthcare costs. Combined pulmonary fibrosis and emphysema (CPFE) combines interstitial lung disease (ILD) and emphysema. Excessive short-acting β2-agonist (SABA) usage escalates exacerbation risk, affecting prognosis.
Frans Raffael, Amira Permatasari Tarigan
openaire   +2 more sources

Home - About - Disclaimer - Privacy